Results 41 to 50 of about 84,996 (200)

Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025

open access: yesEurosurveillance
We measured effectiveness of nirsevimab against laboratory-confirmed respiratory syncytial virus (RSV) infection in a test-negative case-control study among children aged 
VEBIS hospital network RSV IE group
doaj   +1 more source

Viral etiological causes of febrile seizures for respiratory pathogens (EFES Study)

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Background: Febrile seizure is the most common childhood neurological disorder, is an important health problem with potential short- and long-term complications, also leading to economic burden and increased parental anxiety about fevers and seizures ...
Kursat Bora Carman   +19 more
doaj   +1 more source

Human respiratory syncytial virus and coronavirus rates in Iranian elderly patients more than 60 years old with acute respiratory symptoms

open access: yesAdvanced Biomedical Research, 2023
Background: Scientists have believed that a number of risk factors, especially viral infectious agents, can be related to respiratory diseases. Due to the pandemics in 2019, Human Respiratory Syncytial Virus and Coronavirus have attracted the attention ...
Shaian Tavakolian   +3 more
doaj   +1 more source

RSV-specific IgG titer and RSV-IgG avidity do not correlate with disease severity.

open access: yes, 2017
RSV-specific IgG levels in plasma of infants was determined by ELISA using virus particles. RSV-IgG avidity was assessed by supplementing NaSCN during ELISA. (A) RSV-specific IgG levels were displayed versus age.
Ivy Widjaja (128545)   +9 more
core   +1 more source

Bronchiolitis in children ≤ 12 months during the pre-flu season of 2024: A case series

open access: yesSouth African Family Practice
Background: In March 2024, the National Institute for Communicable Diseases (NICD) warned against a respiratory syncytial virus (RSV) outbreak during the pre-flu season, 2024. Globally, RSV is responsible for most respiratory infections in young children.
Marietjie Brits, Hanneke Brits
doaj   +1 more source

Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform

open access: yesHuman Vaccines & Immunotherapeutics, 2018
Peptide antigens are combined with an adjuvant in order to increase immunogenicity in vivo. The immunogenicity and safety of a RSV vaccine formulated in a novel oil-based platform, DepoVax™ (DPX), was compared to an alum formulation.
Lisa D. MacDonald   +9 more
doaj   +1 more source

The incidence and clinical burden of respiratory syncytial virus disease identified through hospital outpatient presentations in Kenyan children [PDF]

open access: yes, 2012
There is little information that describe the burden of respiratory syncytial virus (RSV) associated disease in the tropical African outpatient setting. Methods We studied a systematic sample of children aged
Bett, Ann   +11 more
core   +1 more source

Respiratory Syncytial Virus Infection Induces Expression of Inducible Nitric Oxide Synthase, CD3, and CD8 in Naturally Occurring Pneumonia in Lambs

open access: yesActa Veterinaria, 2021
Respiratory syncytial virus (RSV) is an RNA virus that belongs to the Pneumovirus genus of the Paramyxoviridae family. The aim of this study was to evaluate the expressions of inducible nitric oxide synthetase (iNOS), CD3 (pan T cells), and CD8 ...
Yaman Turan, Aydemir Ceyhun
doaj   +1 more source

RSV-specific IgG against individual RSV glycoproteins do not correlate with disease severity.

open access: yes, 2017
RSV glycoprotein-specific antibody levels were determined by ELISA against recombinant, soluble ectodomains. Median IgG levels (± IQR) were compared between healthy and RSV-infected infants as well as between RSV patients with and without oxygen therapy.
Ivy Widjaja (128545)   +9 more
core   +1 more source

Genome structures of the rHPIV3-RSV-F vectors.

open access: yes, 2020
The codon-optimized RSV F ORF containing the HEK and DS-Cav1 mutations (see Results) was engineered to contain an optimal translational start site (underlined and labeled “Kozak” [36]) and was flanked by HPIV3 gene-end (GE) and gene-start (GS ...
Sonja Surman (185609)   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy